ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q3SCImago #10,636Hybrid

Critical Reviews in Immunology

Abbreviation (ISO):Crit. Rev. Immunol
•
Identifier (ISSN):1040-8401(Print)
•
Publisher:Begell House Inc.
Clarivate IF (2026)
1.8↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Critical Reviews in Immunology

WoS Q4
01231.3520181.1920191.420202.2120211.7420221.320230.820240.920251.82026
Annual Impact Factor Metric
Current (2026):1.8
Scopus SJR & RankScopus Q3
0.558
#10,636

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
91

91 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
13articles/year
2.83% Gold OA•100% Original Research

Aims & Scope

Immunology covers a broad spectrum of investigations at the genes, molecular, cellular, organ and system levels to reveal defense mechanisms against pathogens as well as protection against tumors and autoimmune diseases. The great advances in immunology in recent years make this field one of the most dynamic and rapidly growing in medical sciences. Critical ReviewsTM in Immunology (CRI) seeks to present a balanced overview of contemporary adaptive and innate immune responses related to autoimmunity, tumor, microbe, transplantation, neuroimmunology, immune regulation and immunotherapy from basic to translational aspects in health and disease. The articles that appear in CRI are mostly obtained by invitations to active investigators. But the journal will also consider proposals from the scientific community. Interested investigators should send their inquiries to the editor before submitting a manuscript.

Topics Covered (Recognized by AI)
Medicine89.5%Biology82.1%Genetics79.5%Immunology77.9%Chemistry69.9%Biochemistry66.7%Immune system66.1%Internal medicine61.8%Antigen42.9%Cell biology41.4%Gene33.8%Pathology29.7%T cell28.5%Receptor27.2%Antibody26.4%In vitro25.9%Cytotoxic T cell21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q4
Rank153/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q4
Rank151/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.8
Articles / Year16
Total Citations0
2025
IF0.9
Articles / Year40
Total Citations18
2024
IF0.8
Articles / Year47
Total Citations111
2023
IF1.3
Articles / Year50
Total Citations169
2022
IF1.735
Articles / Year35
Total Citations103

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,636Scopus Q3SCImago Profile
Scopus Coverage:1980-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q3
0.558

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
1.91

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,933 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations180
3-Year Documents97
Citable Documents90

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ3
Immunology and AllergyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Critical Reviews in Immunology (abbr: Crit. Rev. Immunol, ISSN: 1040-8401) is a peer-reviewed international scholarly journal in the field of Medicine, published by Begell House Inc. in United States since 1980. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.558 (Q3), an H-index of 91.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 13 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,933 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Begell House Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1980
Indexing & Databases
SCIEScopusPubMed
Editorial Address
BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4dbff621-b89f-4e61-a47e-fc8f29dabc92
Database Updated: 2026-09-30